Drug Shortage Report for TEVA-ROPINIROLE
| Report ID | 136751 |
| Drug Identification Number | 02316870 |
| Brand name | TEVA-ROPINIROLE |
| Common or Proper name | ROPINIROLE 5MG FC TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ROPINIROLE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 |
| ATC code | N04BC |
| ATC description | DOPAMINERGIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-03-30 |
| Estimated end date | 2024-05-31 |
| Actual end date | 2024-05-29 |
| Shortage status | Resolved |
| Updated date | 2024-05-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v28 | 2024-05-30 | French | Compare |
| v27 | 2024-05-30 | English | Compare |
| v26 | 2024-04-11 | French | Compare |
| v25 | 2024-04-11 | English | Compare |
| v24 | 2024-03-28 | French | Compare |
| v23 | 2024-03-28 | English | Compare |
| v22 | 2024-02-15 | French | Compare |
| v21 | 2024-02-15 | English | Compare |
| v20 | 2023-10-04 | French | Compare |
| v19 | 2023-10-04 | English | Compare |
| v18 | 2022-08-18 | French | Compare |
| v17 | 2022-08-18 | English | Compare |
| v16 | 2022-06-30 | French | Compare |
| v15 | 2022-06-30 | English | Compare |
| v14 | 2021-11-18 | French | Compare |
| v13 | 2021-11-18 | English | Compare |
| v12 | 2021-11-11 | French | Compare |
| v11 | 2021-11-11 | English | Compare |
| v10 | 2021-11-04 | French | Compare |
| v9 | 2021-11-04 | English | Compare |